Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Durgam Laxman

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Structural Chemistry|July 11, 2022
Fragment-based inhibitor design for SARS-CoV2 main proteasePriyanka Andola, Jishu Pagag, Durgam Laxman, et al.
Journal of Biomolecular Structure & Dynamics|April 1, 2026
Computational validation of inhibitors for human phosphatidylinositol 4-phosphate 5-kinase-type 1 α protein implicated in cancerPriyanka Andola, Jishu Pagag, Durgam Laxman, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Structural Chemistry|July 11, 2022
Fragment-based inhibitor design for SARS-CoV2 main proteasePriyanka Andola, Jishu Pagag, Durgam Laxman, et al.
Journal of Biomolecular Structure & Dynamics|April 1, 2026
Computational validation of inhibitors for human phosphatidylinositol 4-phosphate 5-kinase-type 1 α protein implicated in cancerPriyanka Andola, Jishu Pagag, Durgam Laxman, et al.
Pageof 1